Shares of ConvaTec Group PLC (LON:CTEC - Get Free Report) hit a new 52-week high on Wednesday . The stock traded as high as GBX 276.20 ($3.74) and last traded at GBX 275.14 ($3.72), with a volume of 11939867 shares trading hands. The stock had previously closed at GBX 275.80 ($3.73).
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank restated a "buy" rating and issued a GBX 310 ($4.19) target price on shares of ConvaTec Group in a report on Wednesday, March 5th.
View Our Latest Analysis on CTEC
ConvaTec Group Trading Up 1.5%
The company has a debt-to-equity ratio of 85.32, a quick ratio of 0.96 and a current ratio of 2.26. The stock has a market capitalization of £7.22 billion, a P/E ratio of 47.81, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64. The stock has a 50-day moving average price of GBX 257.45 and a two-hundred day moving average price of GBX 245.24.
ConvaTec Group Increases Dividend
The business also recently declared a dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, April 17th will be issued a $0.05 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This represents a yield of 1.36%. This is a boost from ConvaTec Group's previous dividend of $0.02. ConvaTec Group's payout ratio is 84.20%.
Insider Transactions at ConvaTec Group
In other ConvaTec Group news, insider Karim Bitar sold 132,253 shares of the firm's stock in a transaction on Friday, March 14th. The stock was sold at an average price of GBX 256 ($3.46), for a total transaction of £338,567.68 ($458,143.00). Corporate insiders own 19.65% of the company's stock.
About ConvaTec Group
(
Get Free Report)
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
See Also
Before you consider ConvaTec Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ConvaTec Group wasn't on the list.
While ConvaTec Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
